FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients who relied on more affordable options.
Nissan's stock surges amid speculation of a potential investment from Tesla, as the automaker faces financial struggles and seeks strategic partners.
FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients who relied on more affordable options.
Nissan's stock surges amid speculation of a potential investment from Tesla, as the automaker faces financial struggles and seeks strategic partners.